联系方式
抗体
| 结构式 | 货号 | 产品名称 | CAS号 |
|---|
 |
BCP46216 | Quavonlimab 新 | 2254059-25-9 |
Quavonlimab (MK-1308), a novel anti-CTLA-4 antibody, in combination with pembrolizumab was investigated in a phase I study.
|
|||
 |
BCP46215 | Naxitamab 新 | 1879925-92-4 |
Naxitamab is a GD2-targeted IgG1 monoclonal antibody for the treatment of high-risk relapsed/refractory neuroblastoma of the bone or bone marrow.
|
|||
 |
BCP46214 | Odesivimab 新 | 2135632-30-1 |
Odesivimab is part of a product containing three monoclonal IgG1κ antibodies directed against the GP1,2 glycoprotein of Zaire ebolavirus.
|
|||
 |
BCP46199 | Etokimab 新 | 2022981-44-6 |
Etokimab, an anti-IL-33 biologic, has previously demonstrated a good safety profile and favorable pharmacodynamic properties in many clinical studies.
|
|||
 |
BCP44227 | Telimomab Aritox 新 | 117305-33-6 |
 |
BCP44817 | Citatuzumab Bogatox 新 | 945228-49-9 |
Citatuzumab bogatox is a monoclonal antibody Fab fragment fused with bouganin, a ribosome inactivating protein from the plant Bougainvillea spectabilis.
|
|||
 |
BCP44818 | Oportuzumab Monatox 新 | 945228-48-8 |
Oportuzumab monatox is an antineoplastic.
|
|||
 |
BCP44819 | Cergutuzumab Amunaleukin 新 | 1509916-03-3 |
Cergutuzumab amunaleukin is a novel CEA-targeted immunocytokine.
|
|||
 |
BCP44820 | Tucotuzumab Celmoleukin 新 | 339986-90-2 |
 |
BCP44821 | Talizumab 新 | 380610-22-0 |
Talizumab is a humanized monoclonal antibody that was under development by Tanox in Houston, Texas as a new-concept therapeutic for allergic diseases.
|
|||
